切口 发表于 2025-3-21 17:41:59
书目名称Combination Cancer Therapy影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0229856<br><br> <br><br>书目名称Combination Cancer Therapy影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0229856<br><br> <br><br>书目名称Combination Cancer Therapy网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0229856<br><br> <br><br>书目名称Combination Cancer Therapy网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0229856<br><br> <br><br>书目名称Combination Cancer Therapy被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0229856<br><br> <br><br>书目名称Combination Cancer Therapy被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0229856<br><br> <br><br>书目名称Combination Cancer Therapy年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0229856<br><br> <br><br>书目名称Combination Cancer Therapy年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0229856<br><br> <br><br>书目名称Combination Cancer Therapy读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0229856<br><br> <br><br>书目名称Combination Cancer Therapy读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0229856<br><br> <br><br>冒号 发表于 2025-3-21 21:18:47
Cancer Drug Discovery and Developmenthttp://image.papertrans.cn/c/image/229856.jpgOutmoded 发表于 2025-3-22 03:59:06
https://doi.org/10.1385/1592598641Chemotherapie; apoptosis; carcinoma; cell; leukemia; ovarian cancer附录 发表于 2025-3-22 08:15:50
http://reply.papertrans.cn/23/2299/229856/229856_4.png北京人起源 发表于 2025-3-22 10:19:04
http://reply.papertrans.cn/23/2299/229856/229856_5.png擦掉 发表于 2025-3-22 13:47:04
,Modelling “Nano-Effects” in Sintering,ath process (apoptosis) (.) and progress in the development of molecularly targeted agents directed against specific oncogenes and enzymes responsible for neoplastic transformation, e.g., STI571 in the case of Bcr/Abl+ malignancies (.). Such efforts have served to focus attention on two general clas擦掉 发表于 2025-3-22 17:52:56
http://reply.papertrans.cn/23/2299/229856/229856_7.pnggregarious 发表于 2025-3-22 21:35:29
http://reply.papertrans.cn/23/2299/229856/229856_8.png询问 发表于 2025-3-23 02:07:26
Role of Grain Boundaries in Sinteringornerstone of present-day developmental chemotherapy. From its rational synthesis by Heidelberger in 1957 (.) to quantification of the molecular determinants of fluorinated pyrimidine (fluoropyrimidine) activity, our understanding of fluoropyrimidine pharmacology has helped mold our concepts of everMendicant 发表于 2025-3-23 07:28:38
http://reply.papertrans.cn/23/2299/229856/229856_10.png